Eija Nissilä

562 total citations
13 papers, 405 citations indexed

About

Eija Nissilä is a scholar working on Molecular Biology, Surgery and Epidemiology. According to data from OpenAlex, Eija Nissilä has authored 13 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Surgery and 3 papers in Epidemiology. Recurrent topics in Eija Nissilä's work include Cholesterol and Lipid Metabolism (4 papers), Inflammatory Bowel Disease (3 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Eija Nissilä is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Inflammatory Bowel Disease (3 papers) and Atherosclerosis and Cardiovascular Diseases (2 papers). Eija Nissilä collaborates with scholars based in Finland, Netherlands and Greece. Eija Nissilä's co-authors include Vesa M. Olkkonen, Seppo Meri, Katri Korpela, Anne Salonen, Päivi Saavalainen, Marion Weber‐Boyvat, Jari Metso, Yuki Ohsaki, Karita Haapasalo and Julia Perttilä and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Eija Nissilä

12 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eija Nissilä Finland 10 222 137 77 67 60 13 405
Nathalie Jouvet Canada 10 241 1.1× 103 0.8× 110 1.4× 101 1.5× 54 0.9× 13 495
Joerg-Dieter Schulzke Germany 6 164 0.7× 112 0.8× 74 1.0× 96 1.4× 52 0.9× 6 385
Lauren C. Binge Australia 7 320 1.4× 87 0.6× 113 1.5× 105 1.6× 27 0.5× 8 535
Luke N. Robinson United States 7 246 1.1× 138 1.0× 33 0.4× 28 0.4× 82 1.4× 8 448
Tetsuya Takagawa Japan 10 175 0.8× 100 0.7× 179 2.3× 88 1.3× 69 1.1× 23 544
Caroline Hall United States 10 165 0.7× 48 0.4× 134 1.7× 73 1.1× 89 1.5× 16 417
Akemi Ota Japan 9 178 0.8× 123 0.9× 68 0.9× 31 0.5× 41 0.7× 23 405
Erin C. Steinbach United States 10 254 1.1× 91 0.7× 232 3.0× 102 1.5× 46 0.8× 18 569
Mylène Blais Canada 13 278 1.3× 73 0.5× 52 0.7× 111 1.7× 25 0.4× 18 466
Huhehasi Wu Japan 13 198 0.9× 61 0.4× 84 1.1× 51 0.8× 111 1.9× 23 521

Countries citing papers authored by Eija Nissilä

Since Specialization
Citations

This map shows the geographic impact of Eija Nissilä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eija Nissilä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eija Nissilä more than expected).

Fields of papers citing papers by Eija Nissilä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eija Nissilä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eija Nissilä. The network helps show where Eija Nissilä may publish in the future.

Co-authorship network of co-authors of Eija Nissilä

This figure shows the co-authorship network connecting the top 25 collaborators of Eija Nissilä. A scholar is included among the top collaborators of Eija Nissilä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eija Nissilä. Eija Nissilä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Nissilä, Eija, Pinja Jalkanen, Katarzyna Leskinen, et al.. (2025). The COVID‐19 vaccine ChAdOx1 is opsonized by anti‐vector antibodies that activate complement and promote viral vector phagocytosis. Scandinavian Journal of Immunology. 101(2). e70000–e70000.
2.
Reeve, Mary Pat, Stephanie Loomis, Eija Nissilä, et al.. (2025). Loss of CFHR5 function reduces the risk for age-related macular degeneration. Nature Communications. 16(1). 5766–5766. 1 indexed citations
3.
Korpela, Katri, Eija Nissilä, Evgenia Dikareva, et al.. (2022). Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 29(1). 116–124. 14 indexed citations
4.
Nissilä, Eija, Hanna Ruhanen, Martina B. Lorey, et al.. (2021). Streptococcus pneumoniae pneumolysin and neuraminidase A convert high-density lipoproteins into pro-atherogenic particles. iScience. 24(6). 102535–102535. 6 indexed citations
5.
Korpela, Katri, Seppo Virtanen, Taina Sipponen, et al.. (2020). Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 15(6). 1019–1031. 47 indexed citations
6.
Nissilä, Eija, Katarzyna Leskinen, Kok P. M. van Kessel, et al.. (2018). Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages. Frontiers in Immunology. 9. 2701–2701. 27 indexed citations
7.
Nissilä, Eija, François P. Douillard, Jarmo Ritari, et al.. (2017). Genotypic and phenotypic diversity of Lactobacillus rhamnosus clinical isolates, their comparison with strain GG and their recognition by complement system. PLoS ONE. 12(5). e0176739–e0176739. 19 indexed citations
8.
Kaye, Sanna, A. Inkeri Lokki, Eija Nissilä, et al.. (2017). Upregulation of Early and Downregulation of Terminal Pathway Complement Genes in Subcutaneous Adipose Tissue and Adipocytes in Acquired Obesity. Frontiers in Immunology. 8. 545–545. 40 indexed citations
9.
Nissilä, Eija, Katri Korpela, A. Inkeri Lokki, et al.. (2017). C4Bgene influences intestinal microbiota through complement activation in patients with paediatric-onset inflammatory bowel disease. Clinical & Experimental Immunology. 190(3). 394–405. 24 indexed citations
10.
Haapasalo, Karita, Eija Nissilä, Jari Metso, et al.. (2015). Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles. Journal of Biological Chemistry. 290(48). 28977–28987. 30 indexed citations
11.
Metso, Jari, Eija Nissilä, Pirkka‐Pekka Laurila, et al.. (2013). Osbpl8 Deficiency in Mouse Causes an Elevation of High-Density Lipoproteins and Gender-Specific Alterations of Lipid Metabolism. PLoS ONE. 8(3). e58856–e58856. 18 indexed citations
12.
Olkkonen, Vesa M., et al.. (2012). Oxysterols and Their Cellular Effectors. SHILAP Revista de lepidopterología. 2(1). 76–103. 143 indexed citations
13.
Nissilä, Eija, Yuki Ohsaki, Marion Weber‐Boyvat, et al.. (2012). ORP10, a cholesterol binding protein associated with microtubules, regulates apolipoprotein B-100 secretion. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821(12). 1472–1484. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026